"This stops patients from accessing promising therapies & raises prescription drug costs by impeding competition. The agency's staff have callous disregard for the impacts of their daily decisions on costs."
"Ramaswamy's emphasis on reducing FDA bureaucracy contrasts sharply with Kennedy's focus on regulating drug advertisements and enhancing drug safety through more research funding."
Collection
[
|
...
]